NCT04581889View on ClinicalTrials.gov

Prevalence of Antibodies Against SARS-CoV-2 Virus That Causes COVID-19 in Tübingen Children

CompletedOBSERVATIONAL
Enrollment

2,380

Participants

Timeline

Start Date

July 2, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

July 31, 2022

Conditions
Severe Acute Respiratory Syndrome
Interventions
OTHER

Diagnostic test

Presence of antibodies in saliva

Trial Locations (1)

72074

Institute of Tropical Medicine, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER

NCT04581889 - Prevalence of Antibodies Against SARS-CoV-2 Virus That Causes COVID-19 in Tübingen Children | Biotech Hunter | Biotech Hunter